Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Financing Activities: 2018-2024

Historic Cash from Financing Activities for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to -$5.5 million.

  • CureVac N.V's Cash from Financing Activities fell 13.15% to -$1.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.9 million, marking a year-over-year decrease of 9.42%. This contributed to the annual value of -$5.5 million for FY2024, which is 102.20% down from last year.
  • Per CureVac N.V's latest filing, its Cash from Financing Activities stood at -$5.5 million for FY2024, which was down 102.20% from $248.4 million recorded in FY2023.
  • CureVac N.V's 5-year Cash from Financing Activities high stood at $977.5 million for FY2020, and its period low was -$5.5 million during FY2024.
  • Over the past 3 years, CureVac N.V's median Cash from Financing Activities value was $64.5 million (recorded in 2022), while the average stood at $102.5 million.
  • In the last 5 years, CureVac N.V's Cash from Financing Activities spiked by 1,199.06% in 2020 and then tumbled by 102.20% in 2024.
  • CureVac N.V's Cash from Financing Activities (Yearly) stood at $977.5 million in 2020, then tumbled by 59.63% to $394.6 million in 2021, then crashed by 83.67% to $64.5 million in 2022, then spiked by 285.44% to $248.4 million in 2023, then slumped by 102.20% to -$5.5 million in 2024.